Show simple item record

dc.contributor.authorPogue, J.M.
dc.contributor.authorHeil, E.L.
dc.date.accessioned2019-09-16T15:13:01Z
dc.date.available2019-09-16T15:13:01Z
dc.date.issued2019
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85072025712&doi=10.1080%2f14656566.2019.1663827&partnerID=40&md5=2a952d40358a6518df921afb58d8f6a7
dc.identifier.urihttp://hdl.handle.net/10713/10859
dc.description.abstracten_US
dc.description.urihttps://doi.org/10.1080/14656566.2019.1663827en_US
dc.language.isoen-USen_US
dc.publisherTaylor and Francis Ltden_US
dc.relation.ispartofExpert Opinion on Pharmacotherapy
dc.subjectantimicrobial resistanceen_US
dc.subjectbeta-lactamase inhibitoren_US
dc.subjectExtended-spectrum betaen_US
dc.subjectgram-negative infectionsen_US
dc.subjectlactamaseen_US
dc.titleLaces out Dan! The role of tazobactam based combinations for invasive ESBL infections in a post-MERINO worlden_US
dc.typeArticleen_US
dc.identifier.doi10.1080/14656566.2019.1663827
dc.identifier.pmid31496320


This item appears in the following Collection(s)

Show simple item record